Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142035 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142036 |
| CAS No | NA |
| Mol.F. | C19H21FN2O2 |
| Mol.Wt. | 328.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142037 |
| CAS No | NA |
| Mol.F. | C22H25FN2O5 |
| Mol.Wt. | 416.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142038 |
| CAS No | NA |
| Mol.F. | C22H25ClF2N2O5 |
| Mol.Wt. | 434.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142039 |
| CAS No | NA |
| Mol.F. | C28H32F2N2O11 |
| Mol.Wt. | 610.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142040 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O6 |
| Mol.Wt. | 450.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142041 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O5 |
| Mol.Wt. | 434.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142042 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142043 |
| CAS No | NA |
| Mol.F. | C18H19FN2O3 |
| Mol.Wt. | 330.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142044 |
| CAS No | NA |
| Mol.F. | C8H8ClN7O |
| Mol.Wt. | 253.7 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142045 |
| CAS No | NA |
| Mol.F. | C6H6N6O2 |
| Mol.Wt. | 194.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142046 |
| CAS No | NA |
| Mol.F. | C17H19N5O10 |
| Mol.Wt. | 453.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142047 |
| CAS No | NA |
| Mol.F. | C11H13N5O7 |
| Mol.Wt. | 327.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142048 |
| CAS No | NA |
| Mol.F. | C10H10N6O8 |
| Mol.Wt. | 342.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142049 |
| CAS No | NA |
| Mol.F. | C16H16N6O11 |
| Mol.Wt. | 468.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142050 |
| CAS No | NA |
| Mol.F. | C6H6N6O3 |
| Mol.Wt. | 210.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |